Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 4, 2011, Pages 500-510

  Rastogi, Ruchi ^a   Du, Wenjin ^a   Ju, Donhong ^a   Pirockinaite, Gaila ^a   Liu, Yusen ^b   Nunez, Gabriel ^c   Samavati, Lobelia ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Dual specificity phosphatase; MAP kinase; p38 MAP kinase; Sarcoidosis

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 23; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TH1 CELL;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; DOWN-REGULATION; DUAL SPECIFICITY PHOSPHATASE 1; FEMALE; HUMANS; MALE; NOD1 SIGNALING ADAPTOR PROTEIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SARCOIDOSIS, PULMONARY; TOLL-LIKE RECEPTOR 4;

EID: 78651437519     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201005-0792OC     Document Type: Article

References (52)

1. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-755.
2. Mathew S, Bauer KL, Fischoeder A, Bhardwaj N, Oliver SJ. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol 2008;181:746-755.
3. Prior C, Knight RA, Herold M, Ott G, SpiteriMA. Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 1996;9:47-53.
4. Chen ES, Wahlstrom J, Song Z, Willett MH, Wiken M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008;181:8784-8796.
5. Furukawa A, Uchida K, Ishige Y, Ishige I, Kobayashi I, Takemura T, Yokoyama T, Iwai K, Watanabe K, Shimizu S, et al. Characterization of propionibacterium acnes isolates from sarcoid and non-sarcoid tissues with special reference to cell invasiveness, serotype, and trigger factor gene polymorphism. Microb Pathog 2009;46:80-87.
6. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999;354:120-123. (Pubitemid 29313147)
7. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med 2006;84:712-725. (Pubitemid 44328063)
8. Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA, Collins C, Viala J, Ferrero RL, Girardin SE, et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007;26:445-459. (Pubitemid 46604867)
9. Inohara C, McDonald C, Nunez G. NOD-LRR proteins: role in hostmicrobial interactions and inflammatory disease. Annu Rev Biochem 2005;74:355-383. (Pubitemid 40995511)
10. Inohara N, Ogura Y, Chen FF, Muto A, Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 2001; 276:2551-2554.
11. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, et al. Host recognition of bacterial muramyl dipeptide mediated through Nod2. Implications for Crohn's disease. J Biol Chem 2003;278:5509-5512. (Pubitemid 36800790)
12. Tanabe T, Ishige I, Suzuki Y, Aita Y, Furukawa A, Ishige Y, Uchida K, Suzuki T, Takemura T, Ikushima S, et al. Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes. Biochim Biophys Acta 2006;1762:794-801. (Pubitemid 44403051)
13. Dong C, Davis RJ, Flavell RA. Map kinases in the immune response. Annu Rev Immunol 2002;20:55-72. (Pubitemid 34293420)
14. Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 1999; 11:211-218. (Pubitemid 29164036)
15. Lee CL, Sit WH, Jiang PP, So IW,Wan JM. Polysaccharopeptide mimics ciclosporin-mediated Th1/Th2 cytokine balance for suppression of activated human T cell proliferation by MAPKp38 and STAT5 pathways. J Pharm Pharmacol 2008;60:1491-1499.
16. Inoue T, Boyle DL, Corr M, Hammaker D, Davis RJ, Flavell RA, Firestein GS. Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. Proc Natl Acad Sci USA 2006;103:5484-5489.
17. Jeffrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specificity phosphatases: manipulating map kinase signalling and immune responses. Nat Rev Drug Discov 2007;6:391-403. (Pubitemid 46705202)
18. Li L, Chen SF, Liu Y. MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. Int J Clin Exp Med 2009;2:48-67.
19. Chi H, Flavell RA. Acetylation of MKP-1 and the control of inflammation. Sci Signal 2008;1:pe44.
20. Tephly LA, Carter AB. Asbestos-induced MKP-3 expression augments TNF-alpha gene expression in human monocytes. Am J Respir Cell Mol Biol 2008;39:113-123. (Pubitemid 351883965)
21. Samavati LDW, Rastogi R, Nuñez G. Nod1 engagement leads to increased il12/il23 p40 and decreased il-10 expressions in sarcoidosis as compared to healthy subjects [abstract]. J Immunol 2009;98.17:182.
22. Samavati L, Rastogi R, Du W, Huttemann M, Fite A, Franchi L. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol 2009;46:1867-1877.
23. Zhao Q, Shepherd EG, Manson ME, Nelin LD, Sorokin A, Liu Y. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem 2005;280:8101-8108. (Pubitemid 40349709)
24. Pratt PF, Bokemeyer D, Foschi M, Sorokin A, Dunn MJ. Alterations in subcellular localization of p38 MAPK potentiates endothelin-stimulated cox-2 expression in glomerular mesangial cells. J Biol Chem 2003;278:51928-51936. (Pubitemid 38020440)
25. Hickey FB, Brereton CF, Mills KH. Adenylate cyclase toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J Leukoc Biol 2008;84:234-243. (Pubitemid 351960299)
26. Pan K, Wang H, Liu WL, Zhang HK, Zhou J, Li JJ, Weng DS, Huang W, Sun JC, Liang XT, et al. The pivotal role of p38 and NF-kappaB signal pathways in the maturation of human monocyte-derived dendritic cells stimulated by streptococcal agent OK-432. Immunobiology 2009;214:350-358.
27. Monick MM, Powers LS, Barrett CW, Hinde S, Ashare A, Groskreutz DJ, Nyunoya T, Coleman M, Spitz DR, Hunninghake GW. Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity. J Immunol 2008;180:7485-7496.
28. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Nunez G, Inohara N. A critical role of RICK/RIP2 polyubiquitination in Nodinduced NF-kappaB activation. EMBO J 2008;27:373-383. (Pubitemid 351161652)
29. Park JH, Kim YG, Shaw M, Kanneganti TD, Fujimoto Y, Fukase K, Inohara N, Nunez G. Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 2007;179:514-521. (Pubitemid 46986568)
30. Samavati L, Monick MM, Sanlioglu S, Buettner GR, Oberley LW, Hunninghake GW. Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am J Physiol Cell Physiol 2002;283:C273-C281. (Pubitemid 34670571)
31. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 2006;103:2274-2279. (Pubitemid 43271660)
32. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC. Glucocorticoids inhibit map kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001;20:7108-7116. (Pubitemid 34062302)
33. Hammer M, Mages J, Dietrich H, Schmitz F, Striebel F, Murray PJ, Wagner H, Lang R. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur J Immunol 2005;35:2991-3001. (Pubitemid 41555095)
34. King EM, Holden NS, Gong W, Rider CF, Newton R. Inhibition of NF-kappaB- dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. J Biol Chem 2009; 284:26803-26815.
35. Hata M, Sugisaki K, Miyazaki E, Kumamoto T, Tsuda T. Circulating IL- 12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers. Intern Med 2007;46:1387-1393.
36. Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, Chen FF, Ogura Y, Nunez G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem 2000;275: 27823-27831.
37. Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007;27:549-559. (Pubitemid 47615512)
38. Shaw MH, Reimer T, Kim YG, Nunez G. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol 2008;20: 377-382.
39. Veltkamp M, Wijnen PA, van Moorsel CH, Rijkers GT, Ruven HJ, Heron M, Bekers O, Claessen AM, Drent M, van den Bosch JM, et al. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 2007;149:453-462. (Pubitemid 47256146)
40. Shigehara K, Shijubo N, Ohmichi M, Takahashi R, Kon S, Okamura H, Kurimoto M, Hiraga Y, Tatsuno T, Abe S, et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 2001;166:642-649. (Pubitemid 32038488)
41. Taha RA, Minshall EM, Olivenstein R, Ihaku D, Wallaert B, Tsicopoulos A, Tonnel AB, Damia R, Menzies D, Hamid QA. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Am J Respir Crit Care Med 1999;160:1119-1123. (Pubitemid 29487448)
42. Adler HS, Kubsch S, Graulich E, Ludwig S, Knop J, Steinbrink K. Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells. Blood 2007;109:4351-4359. (Pubitemid 46743403)
43. Hollenbach E, Vieth M, Roessner A, Neumann M, Malfertheiner P, Naumann M. Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem 2005;280:14981-14988. (Pubitemid 40562850)
44. Monick MM, Powers LS, Gross TJ, Flaherty DM, Barrett CW, Hunninghake GW. Active ERK contributes to protein translation by preventing JNK-dependent inhibition of protein phosphatase 1. J Immunol 2006;177:1636-1645. (Pubitemid 44092499)
45. Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, Liu Y. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol 2002;169:6408-6416. (Pubitemid 36903490)
46. Liu Y, Shepherd EG, Nelin LD. MAPK phosphatases-regulating the immune response. Nat Rev Immunol 2007;7:202-212.
47. Bermudez O, Marchetti S, Pages G, Gimond C. Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway. Oncogene 2008;27:3685-3691. (Pubitemid 351912973)
48. Furukawa T, Tanji E, Xu S, Horii A. Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells. Biochem Biophys Res Commun 2008;377:317-320.
49. Wang X, Meng X, Kuhlman JR, Nelin LD, Nicol KK, English BK, Liu Y. Knockout of MKP-1 enhances the host inflammatory responses to gram-positive bacteria. J Immunol 2007;178:5312-5320. (Pubitemid 46595317)
50. Frazier WJ, Wang X, Wancket LM, Li XA, Meng X, Nelin LD, Cato AC, Liu Y. Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice. J Immunol 2009;183:7411-7419.
51. Cao W, Bao C, Padalko E, Lowenstein CJ. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits toll-like receptor signaling. J Exp Med 2008;205:1491-1503. (Pubitemid 351831502)
52. Brondello JM, Pouyssegur J, McKenzie FR. Reduced map kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 1999;286:2514-2517.